Details

---

Manufacturer
Hetero Labs Limited(INDIA)

Registraction Number
MAL22076002AZ

Contents:
TELDY Film-Coated Tablets contain the following active ingredients:

• Dolutegravir: 50 mg (equivalent to 52.6 mg of dolutegravir sodium)
• Lamivudine: 300 mg
• Tenofovir Disoproxil Fumarate: 300 mg (equivalent to 245 mg of tenofovir disoproxil)

These tablets are used for the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg.
Indications:
TELDY Film-Coated Tablets are indicated for the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg. This combination of dolutegravir, lamivudine, and tenofovir disoproxil fumarate is used as a complete regimen to help manage and control the infection
Instructions:
Here are the general instructions for taking TELDY (Dolutegravir 50mg/Lamivudine 300mg/Tenofovir Disoproxil Fumarate 300mg) Film-Coated Tablets:

1. Dosage: Take one tablet orally, once daily, with or without food. The exact dosage should be determined by your healthcare provider based on your specific condition and treatment plan.
2. Storage: Store below 30°C (86°F) and protect from light and moisture. Keep out of reach of children.
3. Missed Dose: If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not double the dose to catch up.
4. Precautions: Inform your healthcare provider if you have any liver problems, kidney problems, or if you are pregnant or planning to become pregnant. Regular monitoring of liver and kidney function may be required.
5. Interactions: Avoid taking this medication with certain other medications that may interact with it, such as dofetilide. Always inform your healthcare provider about all the medications you are taking.